Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06899750 · ClinicalTrials.gov registry record · NA

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

A NA study of Hypertension, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06899750 is a NA study of Hypertension that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 200 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06899750, a NA study of Hypertension, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL E3 Multidisciplinary Team
  • BEHAVIORAL E3 Self-Guided Hypertension Education Program

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-02-10
Est. Completion 2026-10-01
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT06899750

The ClinicalTrials.gov registry entry for NCT06899750 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which E3 Multidisciplinary Team is the first listed.

NCT06899750 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06899750 about?

NCT06899750 is a clinical study titled "E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control". This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.

What is the current status of trial NCT06899750?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-02-10. Estimated completion is 2026-10-01.

What conditions does trial NCT06899750 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT06899750?

The interventions under investigation include: E3 Multidisciplinary Team (BEHAVIORAL), E3 Self-Guided Hypertension Education Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06899750?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06899750 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.